BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 19092368)

  • 21. Fabry disease--a primer for cardiologists.
    Mursă A; Ginghină C; Jurcut R
    Rom J Intern Med; 2014; 52(4):216-22. PubMed ID: 25726623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
    Thurberg BL; Fallon JT; Mitchell R; Aretz T; Gordon RE; O'Callaghan MW
    Circulation; 2009 May; 119(19):2561-7. PubMed ID: 19414635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal ultrastructural findings in Anderson-Fabry disease.
    Sessa A; Toson A; Nebuloni M; Pallotti F; Giordano F; Battini G; Maglio A; Meroni M; Calconi G; Bertolone G; Gatti P
    J Nephrol; 2002; 15(2):109-12. PubMed ID: 12018625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA; Elliott PM; Shah J; Zuckerman J; Coghlan G; Brookes J; Mehta AB
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Department-related tasks and organ-targeted therapy in Fabry disease: an interdisciplinary challenge.
    Weidemann F; Sommer C; Duning T; Lanzl I; Möhrenschlager M; Naleschinski D; Arning K; Baron R; Niemann M; Breunig F; Schaefer R; Strotmann J; Wanner C
    Am J Med; 2010 Jul; 123(7):658.e1-658.e10. PubMed ID: 20609689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurological manifestations in Fabry's disease.
    Møller AT; Jensen TS
    Nat Clin Pract Neurol; 2007 Feb; 3(2):95-106. PubMed ID: 17279083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anderson-Fabry disease and the heart.
    O'Mahony C; Elliott P
    Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural study of renal involvement in two females with Anderson-Fabry disease.
    Tosoni A; Nebuloni M; Zerbi P; Vago L; Comotti C; Sessa A
    Ultrastruct Pathol; 2005; 29(3-4):203-7. PubMed ID: 16036875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on Fabry disease: kidney involvement, renal progression and enzyme replacement therapy.
    Breunig F; Wanner C
    J Nephrol; 2008; 21(1):32-7. PubMed ID: 18264934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Fabry's disease; towards a treatment].
    Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular features of Fabry disease: diagnosis of a treatable life-threatening disorder.
    Samiy N
    Surv Ophthalmol; 2008; 53(4):416-23. PubMed ID: 18572058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurological complications of Fabry-disease].
    Vastagh I; Constantin T; Kéri A; Rudas G; Fekete G; Bereczki D
    Ideggyogy Sz; 2011 Jan; 64(1-2):29-35. PubMed ID: 21428036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac involvement in Fabry's disease - typical disease course and diagnostic problems].
    Owsiak M; Kwiecień-Sobstel A; Mirek-Bryniarska E; Bryniarski L
    Kardiol Pol; 2011; 69(4):364-6. PubMed ID: 21523672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fabry disease in hemodialysis patients in southern Brazil: prevalence study and clinical report.
    Porsch DB; Nunes AC; Milani V; Rossato LB; Mattos CB; Tsao M; Netto C; Burin M; Pereira F; Matte U; Giugliani R; Barros EJ
    Ren Fail; 2008; 30(9):825-30. PubMed ID: 18925518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fabry disease].
    Kantola I; Penttinen M; Nuutila P; Viikari J
    Duodecim; 2012; 128(7):729-39. PubMed ID: 22612023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fabry disease: renal involvement limited to podocyte pathology and proteinuria in a septuagenarian cardiac variant. Pathologic and therapeutic implications.
    Meehan SM; Junsanto T; Rydel JJ; Desnick RJ
    Am J Kidney Dis; 2004 Jan; 43(1):164-71. PubMed ID: 14712441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A; Winther Bach F; Feldt-Rasmussen U; Rasmussen A; Hasholt L; Lan H; Sommer C; Kølvraa S; Ballegaard M; Staehelin Jensen T
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Fabry-Anderson disease: current state of knowledge].
    Vega-Vega O; Pérez-Gutiérrez A; Correa-Rotter R
    Rev Invest Clin; 2011; 63(3):314-21. PubMed ID: 21888295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG; Ferraz MJ; Rodrigues D; Pais-Vieira M; Lima D; Brady RO; Sousa MM; Sá-Miranda MC
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fabry disease and the skin: data from FOS, the Fabry outcome survey.
    Orteu CH; Jansen T; Lidove O; Jaussaud R; Hughes DA; Pintos-Morell G; Ramaswami U; Parini R; Sunder-Plassman G; Beck M; Mehta AB;
    Br J Dermatol; 2007 Aug; 157(2):331-7. PubMed ID: 17573884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.